References
- 1
Adler G, Grieshaber S, Faude V, Thebaldi B, Dressing H.
Clozapine in Patients with Chronic Schizophrenia: Serum Level, EEG and Memory Performance.
Pharmacopsychiatry.
2002;
35
190-194
- 2
Baker R, Chengappa K NR.
Gastroesophageal Reflux as a Possible Result Of Clozapine Treatment.
Am J Psychiatry.
1998;
59
257
- 3
Barnas C h, Bergant A, Hummer M, Saria A, Fleischhacker W W.
Clozapine Concentrations in Maternal and Fetal Plasma, Amniotic Fluid, and Breast
Milk.
Am J Psychiatry.
1994;
151
945
- 4 Bazire S. Psychotropic Drug Directory. Quay Books Division Salisbury; 2002
- 5
Cannon M, Jones P B, Murray R M.
Obstetric Complications and Schizophrenia: Historical and Meta-Analytic Review.
Am J Psychiatry.
2002;
159
1080-1092
- 6
Patton S W, Misri S, Korral M R, Perry K F, Kuan A J.
Antipsychotic Medication During Pregnancy and Lactation in Women With Schizophrenia:
Evaluating the Risk.
Can J Psychiatry.
2002;
47
959-965
- 7
Pinkofsky H, Fitz-Gerald M, Reeves R.
Psychotropic Treatment During Pregnancy.
Am J Psychiatry.
1997;
154
718-719
- 8 Rzewuska M. Leczenie zaburzeá psychicznych. PZWL Warszawa; 2000
- 9
Stoner S, Sommi R, Marken P, Anya I, Vaughn J.
Clozapine Use in Two Full-Term Pregnancies.
Am J Psychiatry.
1997;
58
364-365
- 10
Wahlbeck K, Forsen T, Osmond C, Barker D JP, Eriksson J.
Association of Schizophrenia With Low Maternal Body Mass Index, Small Size at Birth
and Thinness During Childhood.
Arch Gen Psychiatry.
2001;
58
48-52
H. Karakula, M.D., PhD.
Department of Psychiatry
Medical University of Lublin
Ul. Kurantowa 4 m. 117
20-836 Lublin
Poland
Email: karakulahw@poczta.onet.pl
